• Home
  • Search
  • Biophysical Screening for the Discovery of Small-Molecule Ligands
  • Open Access IconOpen Access
  • Cite Icon76
  • https://doi.org/10.1007/978-1-62703-398-5_13Copy DOI Icon

Biophysical Screening for the Discovery of Small-Molecule Ligands

  • Jan 1, 2013
  • Alessio Ciulli
Show More
  • Abstract
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

Discovering small-molecule chemical probes of protein function has great potential to elucidate biological pathways and to provide early-stage proof-of-concept for target validation. Discovery of such probes therefore underpins many of the chemical biology and drug discovery efforts in both academia and the pharmaceutical industry. The process generally begins with screening small molecules to identify bona fide "hits" that bind non-covalently to a target protein. This chapter is concerned with the application of biophysical and structural techniques to small-molecule ligand screening, and with the validation of hits from both structural (binding mode) and energetic (binding affinity) stand-points. The methods discussed include differential scanning fluorimetry (thermal shift), fluorescence polarization (FP), surface plasmon resonance, ligand-observed NMR spectroscopy, isothermal titration calorimetry, and protein X-ray crystallography. The principles of these techniques and the fundamental nature of the observables used to detect macromolecule-ligand binding are briefly outlined. The practicalities, advantages, and disadvantages of each technique are described, particularly in the context of detecting weak affinities, as relevant to fragment screening. Fluorescence-based methods, which offer an attractive combination of high throughput and low cost are discussed in detail. It is argued that applying a combination of different methods provides the most robust and effective way to identify high-quality starting points for follow-up medicinal chemistry and to build structure-activity relationships that better inform effective development of high-quality, cell-active chemical probes by structure-based drug design.

Similar Papers
  • Research Article
  • Citations4

Unlocking the potential of chemical probes for methyl-lysine reader proteins.

  • Sep 01, 2015
  • Future Medicinal Chemistry
  • Stephen V Frye
  • Research Article

Abstract B25: Discovery of molecular probes inhibiting La:RNA interactions in cancer cells

  • Mar 14, 2017
  • Cancer Research
  • Gunhild Sommer +4
  • Research Article

Effective and emerging strategies for utilizing structure in drug discovery. Cambridge, UK - March 19, 2015

  • Jan 01, 2015
  • Drugs of the Future
  • Brown, K.A +2
  • Research Article
  • Citations1

Abstract 3279: Dual inhibition of EZH2 and histone deacetylases for the treatment of lymphomas with epigenetic aberrations

  • Jun 15, 2022
  • Cancer Research
  • Afua Adjeiwaa Mensah +10
  • Research Article
  • Citations46

Discovery of Nanomolar-Affinity Pharmacological Chaperones Stabilizing the Oncogenic p53 Mutant Y220C.

  • Oct 11, 2022
  • ACS pharmacology & translational science
  • Joseph R Stephenson Clarke +7
  • Book Chapter
  • Citations4

Chapter 5. Contribution of Structure-Based Drug Design to the Discovery of Marketed drugs

  • Nov 04, 2011
  • Alexander A Alex +1
  • Research Article
  • Citations1

Abstract 4648: In vitro characterization of spiro-oxindole-based modulators of the MDM2-p53 interaction and their interspecies selectivity.

  • Apr 15, 2012
  • Cancer Research
  • Christine Delaisi +28
  • PDF
  • Research Article
  • Citations33

The Molecular Chaperone, ClpA, Has a Single High Affinity Peptide Binding Site per Hexamer

  • Apr 01, 2005
  • Journal of Biological Chemistry
  • Grzegorz Piszczek +4
  • Research Article
  • Citations1

Drug discovery through biophysical techniques: Methods and applications.

  • Jan 01, 2026
  • Pharmacology & therapeutics
  • Yinhao Zhou +4
  • Research Article
  • Citations1

Abstract 680: Leveraging an RNA-targeting platform for the discovery of cell-active c-MYC mRNA-binding small molecules

  • Mar 22, 2024
  • Cancer Research
  • Matthew J Smola +7
  • Research Article

Abstract 3298: Structure-based computer-aided drug design to discover novel small molecules that target brain tumor stem cells

  • Apr 15, 2011
  • Cancer Research
  • Chunyu Gu +7
  • Research Article
  • Citations15

Kinetic analysis of interaction of BRCA1 tandem breast cancer c-terminal domains with phosphorylated peptides reveals two binding conformations.

  • Aug 22, 2008
  • Biochemistry
  • Yves Nominé +6
  • PDF
  • Research Article
  • Citations11

Solvated interaction energy: from small-molecule to antibody drug design.

  • Jun 07, 2023
  • Frontiers in Molecular Biosciences
  • Enrico O Purisima +5
  • Dissertation

Kinetic Analysis of Small Molecule Inhibitors Targeting Protein Arginine Methyltransferase-5 (PRMT5) using Surface Plasmon Resonance (SPR)

  • May 01, 2020
  • Lynn Kim Baker +1
  • Research Article
  • Citations45

Direct Proximity Tagging of Small Molecule Protein Targets Using an Engineered NEDD8 Ligase.

  • Sep 28, 2016
  • Journal of the American Chemical Society
  • Zachary B Hill +3
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.